ARCHIVES

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

This article is from The Cancer Letter archive.

Vol. 17 No. 31 | August 2, 1991

Download PDF Visit The Full Archive

Related Articles

Massive New Radiation Research program Costing From $300-$400 Million Over 10 Years Suggested

February 11, 1977

NCI Programs: Institute To Develop Plans For Large Trial Of Spiral CT Scanning For Lung Cancer

November 5, 1999

Abstracts Of Papers From Conference On Adjuvant Therapy

April 22, 1977

Ludwig Cancer Research Donates $540 Million to Six Centers

January 10, 2014

AACR considering new office in D.C.

July 18, 2003

AACR Membership Up 14 Percent Per Year Since ‘88

June 8, 1990